Candesartan

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3076 publications

Computational Analysis of Dual Targeting of β1-Adrenergic and AT1 Receptors by Bisoprolol Fumarate and Candesartan Cilexetil for Hypertensive Modulation.

Computational Analysis of Dual Targeting of β1-Adrenergic and AT1 Receptors by Bisoprolol Fumarate and Candesartan Cilexetil for Hypertensive Modulation.

Journal: Xenobiotica; the fate of foreign compounds in biological systems
Published: June 23, 2026

The effects of angiotensin receptor blockers as prophylactic migraine treatment: A systematic review and meta-analysis.

The effects of angiotensin receptor blockers as prophylactic migraine treatment: A systematic review and meta-analysis.

Journal: Cephalalgia : an international journal of headache
Published: May 29, 2026

Candesartan, Metoprolol and Rosuvastatin Associated to Lower 30-Days Mortality in Adult COVID-19 Patients - A Register Study in Finland before COVID-19 Vaccines.

Candesartan, Metoprolol and Rosuvastatin Associated to Lower 30-Days Mortality in Adult COVID-19 Patients - A Register Study in Finland before COVID-19 Vaccines.

Journal: Journal of primary care & community health
Published: May 22, 2026

Glaucoma Risk Associated With Calcitonin Gene-Related Peptide Inhibitor Use in Migraine: A Multinational Cohort Study.

Glaucoma Risk Associated With Calcitonin Gene-Related Peptide Inhibitor Use in Migraine: A Multinational Cohort Study.

Journal: Neurology
Published: May 06, 2026

Total Abdominal Hysterectomy in a Young Woman With Refractory Abnormal Uterine Bleeding of Multifactorial Etiology: A Case Report of an Incidental Hemorrhagic Ovarian Cyst in a Single Ovary.

Total Abdominal Hysterectomy in a Young Woman With Refractory Abnormal Uterine Bleeding of Multifactorial Etiology: A Case Report of an Incidental Hemorrhagic Ovarian Cyst in a Single Ovary.

Journal: Cureus
Published: April 09, 2026

Superior outcomes of candesartan over topiramate in the treatment of migraine: A comparative cohort study.

Superior outcomes of candesartan over topiramate in the treatment of migraine: A comparative cohort study.

Journal: Cephalalgia : an international journal of headache
Published: March 04, 2026

Cardio- and reno-protective effects of candesartan compared to lisinopril in a rat model of cardiorenal syndrome type 4: implication of oxidative stress and inflammation.

Cardio- and reno-protective effects of candesartan compared to lisinopril in a rat model of cardiorenal syndrome type 4: implication of oxidative stress and inflammation.

Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: March 03, 2026

The effect of multidisciplinary open-label treatment in patients with persistent post-traumatic headache at two tertiary headache centers.

The effect of multidisciplinary open-label treatment in patients with persistent post-traumatic headache at two tertiary headache centers.

Journal: Pain management
Published: February 28, 2026

Rapid quantification method of pharmaceuticals in urban wastewater using UHPLC-Orbitrap mass spectrometry-a multi-target approach for EU-directive advanced treatment evaluation.

Rapid quantification method of pharmaceuticals in urban wastewater using UHPLC-Orbitrap mass spectrometry-a multi-target approach for EU-directive advanced treatment evaluation.

Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: February 25, 2026

Drug repurposing in Alzheimer's disease: Emerging therapeutic strategies and promising candidates.

Drug repurposing in Alzheimer's disease: Emerging therapeutic strategies and promising candidates.

Journal: Ageing research reviews
Published: February 24, 2026

The angiotensin II receptor blocker candesartan mitigates cisplatin-induced myocardial injury via suppression of TLR-4/NF-κB/IRF-3/AP-1 signaling and restoration of antioxidant defenses.

The angiotensin II receptor blocker candesartan mitigates cisplatin-induced myocardial injury via suppression of TLR-4/NF-κB/IRF-3/AP-1 signaling and restoration of antioxidant defenses.

Journal: Tissue & cell
Published: January 26, 2026

Microbial Metabolite 4EPS Inhibits AT1R to Reduce Blood Pressure and Aortic Aneurysm Outcome.

Microbial Metabolite 4EPS Inhibits AT1R to Reduce Blood Pressure and Aortic Aneurysm Outcome.

Journal: Hypertension (Dallas, Tex. : 1979)
Published: January 22, 2026
Showing 1-12 of 3,076

Last Updated: 06/30/2026